Research Catalog

Title

Pharmacology for nurse anesthesiology / edited by Richard G. Ouellette, Joseph Anthony Joyce.

Publication

Sudbury, MA : Jones & Bartlett Learning, c2011.

Items in the Library & Off-site

Details

Additional Authors

• Joyce, Joseph Anthony.
• Ouellette, Richard G.

Description

xvi, 544 p. : ill.; 28 cm.

Summary

"Pharmacology for Nurse Anesthesiology provides appropriate chemical, biological, and physical inforamtion of the actions, interactions, and reactions of medication, particularly as they apply and impact the practice of nurse anesthesia. Written by certified registered nurse anesthetists (CRNAs) for CRNAs, this title presents information about various drugs using theoretical aspects based in chemistry, biochemistry, biology, and physics/biophysics and practical aspects straight from actual CRNAs who administer and deal with the medications on a case-by-case, daily basis." "The perfect resource for both practicing professionals and students in CRNA programs!"--BOOK JACKET.

Subjects

• Anesthetics > pharmacology
• Nurse anesthetists
• Nurse Anesthetists
• Drug Therapy > nursing
• Pharmacology
• Nurses Instruction

Genre/Form

Nurses Instruction.

Bibliography (note)

• Includes bibliographical references and index.

Contents

• SECTION I. General Pharmacologic Concepts -- Chapter 1. Pharmacokinetics: The Study of Drug Disposition -- Objectives -- Introduction -- Pharmacokinetics -- Routes of Administration -- Solubility -- Absorption, Distribution, Metabolism, and Elimination -- Mathematical Modeling -- Dosing Calculations -- Key Points -- Chapter Questions -- References -- Chapter 2. Pharmacodynamics: Study of Drug Action -- Objectives -- Introduction -- Receptor Theory -- Receptor Interactions -- Receptor Regulation -- Receptor Types -- Non-Receptor-Mediated Effects -- Mechanisms of General Anesthesia -- Key Points -- Chapter Questions -- References -- Chapter 3. Cultural, Environmental, and Genetic Influences on Drug Therapy -- Objectives -- Introduction -- Historic Perspective -- Cultural and Environmental Influences -- Genetic Influences -- Conclusion -- Key Points -- Chapter Questions -- References -- SECTION II. Pharmacology of Anesthetic Practice -- Chapter 4. Anesthetic Induction Agents -- Objectives -- Introduction -- Barbiturates -- Etomidate -- Ketamine -- Propofol -- Key Points -- Chapter Questions -- References -- Chapter 5. Benzodiazepines -- Objectives -- Introduction -- Mechanism of Action -- Clinical Pharmacology -- Clinical Uses and Indications -- Side Effects and Contraindications -- Drug Interactions, Guidelines, and Precautions -- Dosages, Administration, and Practical Aspects -- Key Points -- Chapter Questions -- References -- Chapter 6. Opioid Agonists, Antagonists, and Agonist-Antagonists -- Objectives -- Introduction -- History of the Use of Opioids -- Mechanisms of Action -- Clinical Pharmacology -- Clinical Uses and Indications -- Comparative Pharmacology of Other Drugs in Class -- Adverse Effects and Contraindications -- Drug Interactions -- Guidelines and Precautions -- Practical Aspects of Drug Administration (Applications in the Operating Room) -- Key Points -- Chapter Questions -- References -- Chapter 7. Nonopioid Analgesics and Their Role in Anesthesia Practice -- Objectives -- Introduction -- Epidemiology and Etiology -- Pathophysiology -- Mechanisms of Pain -- Cyclooxygenase Inhibitors -- Cyclooxygenase Enzymes -- Classification of NSAIDs -- Side Effects of Nonselective and COX-2 NSAIDs -- Ketamine -- Dextromethorphan -- Centrally Acting a2 Agonists -- Key Points -- Chapter Questions -- References -- Chapter 8. Neuromuscular Blocking Drugs -- Objectives -- Introduction -- Mechanisms of Action -- Clinical Pharmacology (Prototype: Rocuronium) -- Metabolism -- Elimination -- Clinical Uses and Indications -- Side Effects and Contraindications -- Drug Interactions -- Guidelines and Precautions -- Dosage and Administration -- Practical Aspects of Drug Administration -- Key Points -- Chapter Questions -- References -- Chapter 9. Pharmacology of Local Analgesics -- Objectives -- Introduction -- Mechanisms of Action -- Clinical Pharmacology -- Commonly Used Local Anesthetic Agents -- Systemic Administration -- Toxicity -- Systemic Local Anesthetic Toxicity -- Summary -- Key Points -- Chapter Questions -- References -- Chapter 10. Anticholinergics -- Objectives -- Introduction -- Parasympathetic Mechanism of Action -- Muscarinic Receptors -- Muscarinic Receptor Antagonists -- Key Points -- Chapter Questions -- References -- Chapter 11. Anticholinesterases -- Objectives -- Introduction -- Mechanism of Action -- Myasthenia Gravis -- Alzheimer's Dementia -- Clinical Pharmacology -- On the Horizon -- Train-of-Four -- Key Points -- Chapter Questions -- References -- Chapter 12. Inhalation Anesthesia -- Objectives -- Introduction -- Historical Context of Inhalation Anesthetics -- Pharmacokinetic Issues: Uptake and Distribution -- Uptake of Inhaled Anesthetics -- Pharmacodynamics and Inhaled Anesthetics -- Modern Inhaled Anesthetics -- Impact of Inhaled Anesthetics by System -- Other Issues Related to Inhaled Anesthetics -- Key Points -- Chapter Questions -- References -- SECTION III. General Pharmacology -- Chapter 13. Antibiotics -- Objectives -- Introduction -- General Principles -- Pharmacokinetic and Pharmacodynamic Principles -- Antibiotic Selection and Specific Antibiotic Classes -- β-Lactam Compounds -- Aminoglycosides -- Macrolides -- Tetracyclines -- Clindamycin -- Vancomycin -- Fluoroquinolones -- Metronidazole -- Practical Aspects of Antibiotic Use -- Key Points -- Chapter Questions -- References -- Chapter 14. Antiemetic Drugs and Therapies -- Objectives -- Introduction -- Physiology of Emesis -- Selective Serotonin Receptor Antagonists -- Corticosteroids -- Butyrophenones -- Benzamides -- Phenothiazines -- Antihistamines (H1 Receptor Antagonists) -- Anticholinergics -- Neurokinin-1 Receptor Antagonists -- Miscellaneous Drugs and Therapies -- Anesthetic Techniques for Preventing PONV -- Conclusion -- Key Points -- Chapter Questions -- References -- Chapter 15. Prophylaxis for Aspiration Pneumonitis -- Objectives -- Introduction -- Interventions for the Prevention of AP -- Summary and Anesthesia Implications -- Conclusions -- Key Points -- Chapter Questions -- Answers and Discussion -- Acknowledgments -- References -- Chapter 16. Diuretics -- Objectives -- Introduction -- Anatomy and Physiology Associated with Urine Formation -- Diuretic Agents -- Anesthetic Implications -- Key Points -- Chapter Questions -- References -- Chapter 17. Antihypertensive Drugs -- Objectives -- Introduction -- Mechanisms of Action of Antihypertensive Drugs -- Anesthetic Management of Acute Perioperative Hypertension -- Key Points -- Chapter Questions -- References -- Chapter 18. Steroids -- Objectives -- Introduction -- Clinical Pharmacology -- Side Effects and Contraindications -- Drug Interactions -- Practical Aspects of Drug Administration -- Clinical Uses and Indications -- Comparative Pharmacology of Other Drugs in Class -- Dosage and Administration -- Key Points -- Chapter Questions -- Answers and Discussion -- References -- Chapter 19. Herbal and Dietary Supplements -- Objectives -- Introduction -- Historical Perspective -- Legislative Intervention -- Anesthesia Implications -- Preoperative Assessment -- Commonly Used Dietary Supplements -- Summary -- Key Points -- Chapter Questions -- References -- Chapter 20. α-and β-Adrenergic Receptor Agonists and Antagonists -- Objectives -- Introduction -- Catecholamines -- Types of Adrenergic Receptors -- Caution in α-and β-Adrenergic Drug Usage in Geriatric Populations -- Key Points -- Chapter Questions -- References -- Chapter 21. Drug Therapy Associated with Autocoids -- Objectives -- Introduction -- Histamine Agonists and Antagonists -- Bradykinin Agonists and Antagonist -- Serotonin Agonist and Antagonist -- Prostaglandins -- Conclusion -- Key Points -- Chapter Questions -- References -- Chapter 22. Anticoagulants and Their Reversal -- Objectives -- Introduction -- Cascade Model of Coagulation -- Cell-Based Model of Coagulation -- Direct and Indirect Thrombin Inhibitors -- Conclusion -- Key Points -- Chapter Questions -- References -- Chapter 23. Antiarrhythmics -- Objectives -- Introduction -- Muscarinic Receptor Antagonists -- β-Adrenergic Receptor Antagonists -- Calcium Channel Antagonists -- Sodium Channel Blockers -- Amiodarone (Cordarone, Pacerone) -- Adenosine (Adenocard) -- Vasopressin (Antidiuretic Hormone, Arginine Vasopressin) -- Magnesium -- Summary -- Key Points -- Chapter Questions -- Answers and Discussion -- References -- SECTION IV. Pharmacologic Management of Disease: Anesthetic Considerations -- Chapter 24. Malignant Hyperthermia: Dantrolene --
• Objectives -- Malignant Hyperthermia -- Conditions and Disorders in the Differential Diagnosis of MH -- Tests for Diagnosing MH Susceptibility -- Anesthesia for the MH-Susceptible Individual -- Pharmacologic Intervention -- Summary -- Key Points -- Chapter Questions -- References -- Chapter 25. Pharmacology of Asthma: Anesthesia Implications -- Objectives -- Introduction -- Origins -- Incidence -- Pathophysiology -- Signs and Symptoms: Preanesthesia Evaluation -- Differential Diagnosis -- Pharmacologic Intervention: Management and Control of Disease -- Practical Aspects: Surgery and Asthma -- Summary -- Key Points -- Chapter Questions -- References -- Chapter 26. Immune System and Anesthesia: Pharmacologic Implications -- Objectives -- Introduction -- Review of Normal Immune Function -- Drugs Used in the Perioperative Setting -- Anesthetic Technique and Immune System Responses -- Summary -- Key Points -- Chapter Questions -- References -- Chapter 27. Pharmacologic Considerations in Obstetric Anesthesia Practice -- Objectives -- Introduction -- Physiologic Changes of Pregnancy -- Pathophysiologic Conditions in Pregnancy and Postpartum -- Pharmacology of Drugs Used in Obstetric Anesthesia Practice -- Key Points -- Chapter Questions -- References -- Chapter 28. Psychiatric Disorders and Their Pharmacologic Management -- Objectives -- Introduction -- Etiology and Pathophysiology of Common Psychiatric Disorders -- Pharmacologic Management of Psychiatric Disorders -- Anesthesia Considerations in the Patient Treated for Mental Illness -- Anesthesia Considerations in Patients Having ECT -- Key Points -- Chapter Questions -- References -- Chapter 29. Pharmacology of Congestive Heart Failure -- Objectives -- Epidemiology -- Etiology and Pathophysiology -- Classification -- Treatment -- Anesthesia Implications -- Key Points -- Chapter Questions -- References -- SECTION V. Drug Interactions -- Chapter 30. Drugs Interactions of Relevance to the Anesthetist -- Objectives -- Introduction -- Drugs Used for Anesthetic Management and Interactions Pertinent to Anesthesia -- Drugs Pertinent to Anesthesia That Induce or Inhibit Metabolism of Drugs -- Antihypertensive Drug Interactions Pertinent to Anesthesia -- Psychopharmacologic Agent Interactions Pertinent to Anesthesia -- Warfarin (Coumadin) Drug Interactions Pertinent to Anesthesia -- Drug Interactions Pertinent to Anesthesia That Affect Drug Absorption -- Drug Interactions Pertinent to Anesthesia That Affect Drug Distribution -- Cardiac Drug Interactions Pertinent to Anesthesia -- Beta-Blocking Drug Interactions Pertinent to Anesthesia -- Antibiotic Drug Interactions Pertinent to Anesthesia -- Miscellaneous Drug Interactions Pertinent to Anesthesia -- Summary -- Key Points -- Chapter Questions -- References.

ISBN

• 9780763786076
• 0763786071

LCCN

2009054074

Owning Institutions

Columbia University Libraries